Baltimore, MD, United States of America

Michael T Goode

This inventor holds 1 USPTO granted patent. Top assignee: Science & Technology Corporation. Active years: 2006.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael T Goode: Innovator in Immunoassay Technology

Introduction

Michael T Goode is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of immunoassay technology. His innovative approach has led to the development of a patented method that enhances the detection of analytes in various samples.

Latest Patents

Michael T Goode holds a patent for "Immunoassay and reagents and kits for performing the same." This patent describes a sandwich immunoassay that is both simple to perform and sensitive in identifying analytes. The assay constituents, except for the analyte to be detected, are dried for convenience. Upon reconstitution with a sample, a rapid detection capability is achieved within 10 to 15 minutes. The method involves capturing the antigen with an immobilized capture antibody, while a labeled reporter antibody binds to the antigen, forming an immunocomplex that generates a detectable signal.

Career Highlights

Michael T Goode is associated with Science & Technology Corporation, where he applies his expertise in immunoassay technology. His work has contributed to advancements in the field, making significant impacts on research and diagnostics.

Collaborations

Michael collaborates with Deborah L Gatto-Menking, enhancing the innovative efforts within their projects.

Conclusion

Michael T Goode's contributions to immunoassay technology exemplify the impact of innovation in scientific research. His patented methods provide rapid and efficient solutions for analyte detection, showcasing the importance of inventors in advancing technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…